Search research articles
Contact Us
Filters
Showing results (81-90 of 123) with videos related to
Page
of 13
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 20, 2009
Phase II multicenter trial of imatinib in 10 histologic subtypes of sarcoma using a bayesian hierarchical statistical model
Rashmi Chugh, J Kyle Wathen, Robert G Maki, et al.
Sarcoma
|
February 25, 2020
Targeting Refractory Sarcomas and Malignant Peripheral Nerve Sheath Tumors in a Phase I/II Study of Sirolimus in Combination with Ganetespib (SARC023)
AeRang Kim, Yao Lu, Scott H Okuno, et al.
Cancer Discovery
|
March 1, 2017
Phase I, Dose-Escalation, Two-Part Trial of the PARP Inhibitor Talazoparib in Patients with Advanced Germline <i>BRCA1/2</i> Mutations and Selected Sporadic Cancers
Johann de Bono, Ramesh K Ramanathan, Lida Mina, et al.
Future Oncology (London, England)
|
March 9, 2016
Stepwise development of a cancer care delivery research study to evaluate the prevalence of virus infections in cancer patients
Joseph M Unger, Dawn L Hershman, Kathryn B Arnold, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 2024
Phase II Trial of <i>nab-</i>Sirolimus in Patients With Advanced Malignant Perivascular Epithelioid Cell Tumors (AMPECT): Long-Term Efficacy and Safety Update
Andrew J Wagner, Vinod Ravi, Richard F Riedel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 4, 2019
Linsitinib (OSI-906) for the Treatment of Adult and Pediatric Wild-Type Gastrointestinal Stromal Tumors, a SARC Phase II Study
Margaret von Mehren, Suzanne George, Michael C Heinrich, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 12, 2021
<i>nab</i>-Sirolimus for Patients With Malignant Perivascular Epithelioid Cell Tumors
Andrew J Wagner, Vinod Ravi, Richard F Riedel, et al.
MMWR. Morbidity and Mortality Weekly Report
|
November 13, 2015
Meningococcal disease among men who have sex with men - United States, January 2012-June 2015
Hajime Kamiya, Jessica MacNeil, Amy Blain, et al.
JAMA Oncology
|
January 18, 2019
Prevalence of Hepatitis B Virus, Hepatitis C Virus, and HIV Infection Among Patients With Newly Diagnosed Cancer From Academic and Community Oncology Practices
Scott D Ramsey, Joseph M Unger, Laurence H Baker, et al.
Sarcoma
|
August 21, 2019
Targeting Sporadic and Neurofibromatosis Type 1 (NF1) Related Refractory Malignant Peripheral Nerve Sheath Tumors (MPNST) in a Phase II Study of Everolimus in Combination with Bevacizumab (SARC016)
Brigitte C Widemann, Yao Lu, Denise Reinke, et al.
Page
of 13
Search research articles
Search
Showing results (81-90 of 123) with videos related to
Sort By:
Page
of 13
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 20, 2009
Phase II multicenter trial of imatinib in 10 histologic subtypes of sarcoma using a bayesian hierarchical statistical model
Rashmi Chugh, J Kyle Wathen, Robert G Maki, et al.
Sarcoma
|
February 25, 2020
Targeting Refractory Sarcomas and Malignant Peripheral Nerve Sheath Tumors in a Phase I/II Study of Sirolimus in Combination with Ganetespib (SARC023)
AeRang Kim, Yao Lu, Scott H Okuno, et al.
Cancer Discovery
|
March 1, 2017
Phase I, Dose-Escalation, Two-Part Trial of the PARP Inhibitor Talazoparib in Patients with Advanced Germline <i>BRCA1/2</i> Mutations and Selected Sporadic Cancers
Johann de Bono, Ramesh K Ramanathan, Lida Mina, et al.
Future Oncology (London, England)
|
March 9, 2016
Stepwise development of a cancer care delivery research study to evaluate the prevalence of virus infections in cancer patients
Joseph M Unger, Dawn L Hershman, Kathryn B Arnold, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 1, 2024
Phase II Trial of <i>nab-</i>Sirolimus in Patients With Advanced Malignant Perivascular Epithelioid Cell Tumors (AMPECT): Long-Term Efficacy and Safety Update
Andrew J Wagner, Vinod Ravi, Richard F Riedel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 4, 2019
Linsitinib (OSI-906) for the Treatment of Adult and Pediatric Wild-Type Gastrointestinal Stromal Tumors, a SARC Phase II Study
Margaret von Mehren, Suzanne George, Michael C Heinrich, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 12, 2021
<i>nab</i>-Sirolimus for Patients With Malignant Perivascular Epithelioid Cell Tumors
Andrew J Wagner, Vinod Ravi, Richard F Riedel, et al.
MMWR. Morbidity and Mortality Weekly Report
|
November 13, 2015
Meningococcal disease among men who have sex with men - United States, January 2012-June 2015
Hajime Kamiya, Jessica MacNeil, Amy Blain, et al.
JAMA Oncology
|
January 18, 2019
Prevalence of Hepatitis B Virus, Hepatitis C Virus, and HIV Infection Among Patients With Newly Diagnosed Cancer From Academic and Community Oncology Practices
Scott D Ramsey, Joseph M Unger, Laurence H Baker, et al.
Sarcoma
|
August 21, 2019
Targeting Sporadic and Neurofibromatosis Type 1 (NF1) Related Refractory Malignant Peripheral Nerve Sheath Tumors (MPNST) in a Phase II Study of Everolimus in Combination with Bevacizumab (SARC016)
Brigitte C Widemann, Yao Lu, Denise Reinke, et al.
Page
of 13